BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 03/31/23

BlackRock Advisors, LLC (“BlackRock”) announced today name changes for five BlackRock closed-end funds with contingent limited terms (each, a “Trust”). The name changes are being made to increase awareness of the contingent limited term structure and the fact that ther...

2023-03-21 10:23:55 ET Summary Three out of 22 CEF sectors positive on price and 5 out of 22 sectors positive on NAV last week. Delaware/Abrdn mergers are closed. New: adding tables of highest yielding, cheapest and most expensive funds from our screener to the Weekly Roundup....

2023-03-13 21:32:01 ET Summary Interest rates have continued to wreak havoc on growth plays such as BSTZ. With the expectation that the Fed may have to go higher for longer, it can still put some uncertainty on this fund. Despite the risks, I continue to find BSTZ attractive a...

Summary BSTZ is paying out a 10.8% yield from its portfolio of private startups, tech stocks, and semiconductor companies. The CEF recently cut its monthly dividend payout by 16%. This was a forced move with return of capital ramping up in recent months on the back of the pertinent ...

BlackRock Science and Technology Trust II ( NYSE: BSTZ ) declares $0.1613/share monthly dividend , -16% decrease from prior dividend of $0.1920. Forward yield 10.76% Payable March 31; for shareholders of record March 15; ex-div March 14. See BSTZ Dividend Scoreca...

Summary The market started out with a bang in 2023 after a lackluster 2022. My CEF portfolio had some significant losses thanks to poor positioning in tech-related funds and discount widening across the board. BSTZ being my top holding heading into 2022, is one standout detractor th...

BlackRock today announced the release of quarterly fund commentaries for BlackRock Innovation and Growth Trust (NYSE: BIGZ), BlackRock Science and Technology Trust II (NYSE: BSTZ), BlackRock Health Sciences Trust II (NYSE: BMEZ), BlackRock Capital Allocation Trust (NYSE: BCAT), BlackRock ESG Capi...

We’ve seen a big bounce (and 12%+ dividends!) in one particular type of closed-end fund (CEF) this year—and all of my buy indicators suggest this profitable play is still in its early stages. Specifically, I’m talking about tech-focused CEFs—which we’...

Summary Term funds have a few topics making them different that I hope to clear up with today's overview. Term funds can benefit shareholders as NAV is realized one way or another. Given that almost all publicly traded CEFs launched after 2018 are term funds, you likely hold some of...

Summary NBXG's discount has widened since our last update, presenting an even more interesting time to consider the fund. While there are significant headwinds and tech-tilted funds might not be completely out of the woods yet, there have been some signs of stability. At the same ti...